Like many people from outside USA, I don’t really know anything about Maria Menounos. For those in the same boat, let me confirm she is a very well-known personality in USA. A journalist, television presenter and actress. She has hosted Extra and E! News; she was a TV correspondent for Today, Access Hollywood, and co-hosted the Eurovision Song Contest 2006 in Athens, Greece. She also co-created and is currently CEO of online podcast series network AfterBuzz TV. She is currently signed to WWE where she has served as an ambassador since 2013. She hosts the podcast ‘Conversations with Maria Menounos‘. She also has an impressive website here. All in all, she looks like an impressive and inspiring person.
On May 3rd 2023, the News broke that she survived “Pancreatic Cancer” and that headline is currently being shared hundreds of times around the internet. This will go on for days and by default there will be a lot of awareness for Pancreatic Cancer coming out of this news. “Surviving” pancreatic cancer is a big deal when you look at the prognostic data, i.e. it’s an eye-catching headline.
The story was an exclusive from US publication/website People. You can read it here (the headline is theirs not mine) – click on the blue link below.
Maria Menounos Reveals She Survived Pancreatic Cancer (people.com)
I sincerely hope Maria will recover from her surgery and get back to normal life. I wish Maria and her husband Keven, the very best ahead of the arrival of their baby girl, being born via surrogate this summer.
I also wish her the best for the recovery and hope she is getting the best attention and care from doctors who really understand Pancreatic Neuroendocrine Tumors, particularly as she had a brain tumor removed in 2017 and there is mention of a ‘fibroid’. Given that additional information, I hope she has been, or will be, tested for MEN1 just to be on the safe side. I have received many similar comments/messages from other members of the Neuroendocrine Cancer community.
When you dig into the detail, you will see that she was actually diagnosed with a Neuroendocrine Tumor of the Pancreas, ergo, a totally different cancer. You might be thinking ‘so what’ but my point is that the because of the headline, the context of all discussions will be that she has survived a cancer with a 5-year survival rate of around 10% rather than the much higher survival rate figure found in pancreatic Neuroendocrine Tumors (on the basis that almost certainly has a well differentiated NET at an early stage). Consequently, Neuroendocrine Cancer will lose out on awareness just as it did with Steve Jobs and Aretha Franklin (and probably many others we don’t even know about).
So how did this happen? What are the sources of the words and terms used in this story?
You can see from the link above, it’s an interview and so while the source might seem to be People, they probably would have been paraphrasing the interview from words Maria herself has said. Perhaps Maria is quoting from her written medical information or quoting from her doctor. Perhaps People decided on the headline. I doubt if this will ever be made clear.
It does mention Neuroendocrine Tumor in the text, “……a 3.9 cm. mass on her pancreas, with a subsequent biopsy confirming that it was a Stage 2 pancreatic neuroendocrine tumor, a form of cancer. ” But the headline is so key to how others will interpret this news, many people only read the headline and scroll on. Many stations have been reporting it adding a “what you need to know about pancreatic cancer” section, citing statistics and other medical information about a totally different cancer than the one she actually has which is so different in prognostic and therapy terms. Hopefully downstream, reporting will become more accurate. Perhaps the big US NET organisations will make contact with Maria and help with that.
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional. Some content may be generated by AI which can sometimes be misinterpreted. Please check any references attached.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Thanks for reading.
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
- SYHX2008: A New Self‑Injectable subcutaneous Long‑acting Octreotide on the Horizon for NETs
Disclaimer:Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the… Read more: SYHX2008: A New Self‑Injectable subcutaneous Long‑acting Octreotide on the Horizon for NETs - Small tumours – big impact
In oncology, a “small” tumour generally refers to a mass that is 2cm or less in diameter. Tumours under 1 cm are often described as “very small”. These small growths typically fall into the earliest clinical staging categories (such as T1) where they are highly localized and have not spread beyond nearby structures. Tumor Size… Read more: Small tumours – big impact - The Invisibility of Neuroendocrine Tumours (NET) – an awareness post by Ronny Allan
“Invisible cancer” typically refers to malignancies that evade early detection or disguise themselves as other common, non-life-threatening ailments. This term is very frequently associated with Neuroendocrine Tumours which are very often difficult to spot on standard imaging and blood tests. When I was diagnosed, I didn’t even feel ill. It was therefore a bit of… Read more: The Invisibility of Neuroendocrine Tumours (NET) – an awareness post by Ronny Allan - Spotlight on Ovarian Neuroendocrine Neoplasms
Disclaimer: The information in this Spotlight is provided for general information and education only. It is not intended to replace the advice of a qualified healthcare professional, nor to be used for diagnosis or treatment of any medical condition. Always discuss your individual situation, symptoms, test results, and treatment options with your own doctor… Read more: Spotlight on Ovarian Neuroendocrine Neoplasms - Ronny Allan’s Newsletter covering May 2026
Just back from holiday thus why the late publication! Summary of May 2026 on RonnyAllan.NET I think the main story of May is similar to March and April which was a strong blog performance. Other key targets met were the two main primary NET types (small intestine and pancreas) and one not so common(thymus) have finally been… Read more: Ronny Allan’s Newsletter covering May 2026 - Fat‑Soluble Vitamins in Neuroendocrine Tumours (NETs): Why Deficiency Happens and Who Is Most at Risk
This blog provides general educational information only. It does not offer medical advice, diagnosis, or treatment. Patients should always consult their clinical team for personalised guidance. Introduction: What Are Fat‑Soluble Vitamins? Fat‑soluble vitamins — A, D, E and K — are nutrients that can only be absorbed when dietary fat is digested properly. They… Read more: Fat‑Soluble Vitamins in Neuroendocrine Tumours (NETs): Why Deficiency Happens and Who Is Most at Risk - Neuroendocrine Tumours (NETs) – A Spotlight on Vitamin B9 (Folate)
Before you read thisThis information is designed to help you understand how vitamins work in the body and how certain NET-related factors might affect them. It is not a substitute for personalised medical advice. Every NET patient is different — tumour type, treatments, surgery, symptoms, and nutritional needs can vary widely. If you have concerns… Read more: Neuroendocrine Tumours (NETs) – A Spotlight on Vitamin B9 (Folate) - Neuroendocrine Tumours – A Spotlight on Vitamin E (Tocopherols & Tocotrienols)
🟧A general‑population overview with NET‑specific considerations where relevant. Disclaimer: This Spotlight provides general educational information about Vitamin E. It is not a substitute for medical advice. Individual needs vary, particularly for those with conditions affecting digestion or absorption. Always consult your medical team before making changes to supplements or nutrition. What is Vitamin E? Vitamin… Read more: Neuroendocrine Tumours – A Spotlight on Vitamin E (Tocopherols & Tocotrienols) - Neuroendocrine Tumours – A Spotlight on Vitamin A (Retinol)
Disclaimer: This Spotlight provides general educational information about Vitamin A. It is not a substitute for medical advice. Individual needs vary, particularly for those with conditions affecting digestion, absorption, or liver function. Always consult your medical team before making changes to supplements or nutrition. 🟧A general‑population overview with NET‑specific considerations where relevant. What is Vitamin… Read more: Neuroendocrine Tumours – A Spotlight on Vitamin A (Retinol) - 200 Lanreotide Injections: A Milestone in Long‑Term Neuroendocrine Tumour (NET) Management
Disclaimer: Educational and advocacy content only. Not a substitute for medical advice. Two hundred injections. It’s a milestone that carries weight — not because of the number itself, but because of what it represents: continuity, stability, and the lived reality of managing Neuroendocrine Cancer over the long term. Lanreotide has been part of my life… Read more: 200 Lanreotide Injections: A Milestone in Long‑Term Neuroendocrine Tumour (NET) Management
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.
I watched her interview on TV just a couple days ago—- as she was talking about her condition, the light bulb went off that what she barely described was NET cancer—- she even declared that Steve Jobs had it…. I have p-net too…..Amazing that our cancer still hasn’t gotten the exposure that it deserves— another opportunity gone down the drain!🤣
our awareness has gone back years (at least in US)
Great Post Ronnie- Phil